Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.24 Analyst target: $17.67 Upside: 72.56%
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.